[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100190615":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":11,"locations":28,"responsibleParty":42,"collaborators":11,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":52,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":11,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":71,"whyStopped":11,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Pfizer","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Probiotic group","EXPERIMENTAL",null,[13],"Dietary Supplement: ProNutrients Probiotic",{"label":15,"type":16,"description":17,"interventionNames":11},"Control group","NO_INTERVENTION","This is a non-supplemented control group that will follow the same dietary and medication restrictions. The purpose of this group is to ensure results are due to supplementation and not due to random dietary exposure.",[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":11},"DIETARY_SUPPLEMENT","ProNutrients Probiotic","Dosage is 1 individually wrapped packet (1 gram) containing probiotic powder per day for 21 days",[9],[25],{"name":26,"affiliation":5,"role":27},"Pfizer CT.gov Call Center","STUDY_DIRECTOR",[29],{"facility":30,"status":11,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":11},"Pfizer Investigational Site","Boston","Massachusetts","02111","United States","US",{"type":37,"coordinates":38},"Point",[39,40],-71.05977,42.35843,{"lat":40,"lon":39},{"type":43,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100190615","phase-4-fecal-recovery-of-the-probiotic-bacteria-lactobacillus-rhamnosus-gg-lgg-and-bifidobacterium-animalis-subspecies-lactis-bb-12-bb-12-in-healthy-humans-following-daily-consumption-of-a-probiotic-supplement-100190615",false,"NCT01757054","Fecal Recovery of the Probiotic Bacteria Lactobacillus Rhamnosus GG (LGG) and Bifidobacterium Animalis Subspecies Lactis BB-12 (BB-12) in Healthy Humans Following Daily Consumption of a Probiotic Supplement","Randomized, Two Arm, Parallel Group, Open Label, Single Center Prospective Study of the Fecal Recovery of Lactobacillus Rhamnosus GG (LGG) and Bifidobacterium Animalis Subspecies Lactis (BB-12) in Healthy Humans Following Daily Consumption of ProNutrients Probiotic Powder Sachet","LGG BB-12","Inclusion Criteria:\n\nAre between 18-70 years of age. Have regular bowel movements. Are willing and able to attend study visits, undergo limited blood and urine testing, take the nutritional supplement according to the instructions provided.\n\nAre willing to collect four stool specimens and bring them to the study site.\n\nExclusion Criteria:\n\nAre unwilling to follow the dietary guidelines of the study. Are lactose-intolerant or have allergies to milk or wheat. Have had drug or alcohol problems within the previous year. Are or plan to become pregnant over the next 3 months.",true,"ALL","18 Years","70 Years",{"count":57,"type":58},27,"ACTUAL","INTERVENTIONAL",[61],"PHASE4","The main hypothesis of this study is that there will be a significant increase of Lactobacillus rhamnosus GG (LGG) and Bifidobacterium lactis (BB-12) in the stool of healthy humans following daily consumption of a probiotic supplement containing these specific strains of probiotic bacteria.",[64],"Fecal Analysis",[66,67,68,69,70],"probiotic","LGG","BB-12","fecal recovery","healthy subjects","COMPLETED","2013-10-29",{"date":74,"type":75},"2013-10-30","ESTIMATED",{"date":77,"type":11},"2013-02",{"date":79,"type":58},"2013-10",{"name":5,"class":6},1]